Results 151 to 160 of about 14,077 (253)

Recurrence Rate and Associated Factors of Mucinous Borderline Ovarian Tumors and Mucinous Ovarian Carcinomas: A Retrospective Study in the South of Vietnam. [PDF]

Diagnostics (Basel)
Vo TM, Le H, Huynh U, Tran TL, Chau NV, Nguyen NH.   +5 more
europepmc   +1 more source

Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature. [PDF]

Cancers (Basel), 2023
Wetterwald L, Sarivalasis A, Liapi A, Mathevet P, Achtari C.   +4 more
europepmc   +1 more source

Merkel cell carcinoma: an updated guide for pathologists

Histopathology, EarlyView.
Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma for which the differential diagnosis can include other small cell malignancies (especially metastatic small cell carcinoma) or cutaneous carcinoma. Morphologic and immunophenotypic aberrancies in MCC can increase diagnostic challenge.
Paul W. Harms
wiley   +1 more source

Clinicopathological Diagnosis and Prognosis of Endometrioid Borderline Ovarian Tumors: Dual Case Reports and Literature Review. [PDF]

Cancer Rep (Hoboken)
Yang F, Chen D, Sun Q, Yu J, Wang X.
europepmc   +1 more source

Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan. [PDF]

Eur J Transl Myol, 2022
Sharami SRY, Farhadifar F, Tabatabaei R.
europepmc   +1 more source

Additional sectioning and AI‐assisted diagnosis reveal underdiagnosis of serous (pre)malignancies in fallopian tube specimen from BRCA1/2 carriers

Histopathology, EarlyView.
This paper shows that deeper sections reveal additional STICs and HGSCs in risk‐reducing salpingo‐oophorectomy specimens of patients who did not have a STIC or HGSC diagnosis but did develop peritoneal HGSC 10 years after surgery. This adds to the premise that HGSC originates in the fallopian tube.
Anouk B Bouwmeester, Tamar A Gootzen, Marielle Nobbenhuis, Vilius Rudaitis, Caroline B van den Berg, Heleen J van Beekhuizen, Luthy SM Alcalá, Dineke PM Smedts, Nicole CM Visser, Viola Verhoef, Trudy GN Jonges, Ronald P Zweemer, Alicia Leon‐Catillo, Carlijn Lems, Joanne A de Hullu, Jeroen AWM van der Laak, Miranda P Steenbeek, Michiel Simons   +17 more
wiley   +1 more source

A Deep Learning Approach for Classifying Benign, Malignant, and Borderline Ovarian Tumors Using Convolutional Neural Networks and Generative Adversarial Networks. [PDF]

Med Sci (Basel)
Giourga M, Petropoulos I, Stavros S, Potiris A, Goula K, Moustakli E, Papahliou AM, Daskalaki MA, Segou M, Rodolakis A, Daskalakis G, Domali E.   +11 more
europepmc   +1 more source

Develop a nomogram to predict overall survival of patients with borderline ovarian tumors. [PDF]

World J Clin Cases, 2022
Gong XQ, Zhang Y.
europepmc   +1 more source

Development and application of a frailty index derived from patient‐reported outcome measures and comorbidities in oncology patients

Internal Medicine Journal, EarlyView.
Abstract Background Emerging evidence supports the use of a frailty index as an objective measure of frailty. We constructed a frailty index from patient‐derived outcome measures, as well as self‐reported comorbidity data, and tested its correlation with survival.
Divya Mathew, Heather Lane, David Ward, Rosemary Saunders, Lesley Millar, Christopher Etherton‐Beer   +5 more
wiley   +1 more source

Use of intraoperative ultrasound in resection of early-stage borderline ovarian tumors: <i>A case series</i>. [PDF]

Gynecol Oncol Rep
Natarajan K, Boo M, Saidi SA.
europepmc   +1 more source